Guidelines on nicotine dose selection for in vivo research
The DOI matches its Crossref record; 451 of the 451 references it cites were found in a registry or an index.
Abstract
Rationale This review provides insight for the judicious selection of nicotine dose ranges and routes of administration for in vivo studies. The literature is replete with reports in which a dosaging regimen chosen for a specific nicotine-mediated response was suboptimal for the species used. In many cases, such discrepancies could be attributed to the complex variables comprising species-specific in vivo responses to acute or chronic nicotine exposure. Objectives This review capitalizes on the authors' collective decades of in vivo nicotine experimentation to clarify the issues and to identify the variables to be considered in choosing a dosaging regimen. Nicotine dose ranges tolerated by humans and their animal models provide guidelines for experiments intended to extrapolate to human tobacco exposure through cigarette smoking or nicotine replacement therapies. Just as important are the nicotine dosaging regimens used to provide a mechanistic framework for acquisition of drug-taking behavior, dependence, tolerance, or withdrawal in animal models. Results Seven species are addressed: humans, nonhuman primates, rats, mice, Drosophila, Caenorhabditis elegans, and zebrafish. After an overview on nicotine metabolism, each section focuses on an individual species, addressing issues related to genetic background, age, acute vs chronic exposure, route of administration, and behavioral responses. Conclusions The selected examples of successful dosaging ranges are provided, while emp…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“When extracting and comparing doses across studies it is critical to evaluate whether doses were reported in free base weight or salt weight as there are large differences between the two forms (Matta et al., 2007).”
From Age-dependent Effects of Tobacco Smoke and Nicotine on Cognition and the Brain: A Systematic Review of the Human and Animal Literature Comparing Adolescents and Adults. (2023) · cites this paper as Matta et al., 2007
In the citing paper
“Mice metabolise nicotine at a faster rate than rats (Matta et al., 2007).”
From Age-dependent Effects of Tobacco Smoke and Nicotine on Cognition and the Brain: A Systematic Review of the Human and Animal Literature Comparing Adolescents and Adults. (2023) · cites this paper as Matta et al., 2007
In the citing paper
“The routes of administration and doses of nicotine in studies can vary widely (Table 1, [152].”
From Adolescent nicotine exposure and persistent neurocircuitry changes: unveiling lifelong psychiatric risks (2025) · cites this paper as [152]
In the citing paper
“nicotine is rapidly metabolized, resulting in a very short half-life in the mouse of 6–7 min”
From Parallel Anxiolytic-Like Effects and Upregulation of Neuronal Nicotinic Acetylcholine Receptors Following Chronic Nicotine and Varenicline (2011) · cites this paper as Matta et al., 2007
In the citing paper
“The experiments use a nicotine concentration (0.1 µM) somewhat less than that in the blood within a few min after a human smokes a cigarette, and perhaps more appropriate to the average values during a day of smoking (Matta et al., 2007).”
From Nicotine up-regulates α4β2 nicotinic receptors and ER exit sites via stoichiometry-dependent chaperoning (2011) · cites this paper as Matta et al., 2007
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Items 401–451 of 451
Drosophila acetylcholinesterase: Characterization of different mutants resistant to insecticides
Pralavorio, M., & Fournier, D. (1992) · Biochemical Genetics · doi:10.1007/bf00554429 · Cited by 31 · cited 1×
“1980) and resistance to insecticides (Fournier et al. 1993; Pralavorio and Fournier 1992).”
Nicotine/mecamylamine combination treatment for smoking cessation
Rose, J. E., Westman, E. C., & Behm, F. M. (1996) · Drug Development Research · doi:10.1002/(sici)1098-2299(199607/08)38:3/4<243::aid-ddr13>3.0.co;2-# · Cited by 31
Multiple nicotinic acetylcholine receptor genes are expressed in goldfish retina and tectum
Cauley, K. A., Agranoff, B., & Goldman, D. A. (1990) · Journal of Neuroscience · doi:10.1523/jneurosci.10-02-00670.1990 · Cited by 31
Role of the fourth cerebroventricle in mediating rat plasma ACTH responses to intravenous nicotine.
Matta, S. G., McAllen, K. M., & Sharp, B. M. (1990) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)19962-x · Cited by 31
Self-citationDomino, E. F., Ni, L., & Zhang, H. (1999) · Experimental Neurology · doi:10.1006/exnr.1999.7106 · Cited by 30 · cited 1×
“The effect of nicotine on locomotor activity has been determined in hemiparkinsonian macaques (M. nemestrina; Domino et al. 1999) in whom nicotine attenuates the antiparkinsonian action of L-dopa at doses ranging from 32 to 320 μg kg administered once daily for 6 days.”
BackgroundSudo, S., Sudo, M., Simons, C. T., Dessirier, J.-M., & Carstens, E. (2002) · Pain · doi:10.1016/s0304-3959(02)00025-8 · Cited by 30 · cited 1×
“Oral nicotine has been shown to activate taste pathways (Carstens et al. 2000; Dahl et al. 1997; Sudo et al. 2002) and these solutions are not particularly palatable, frequently requiring pre-training periods in which daily nicotine is combined with receding doses of saccharin over weeks of access, akin to the sucrose…”
MethodMatta, S. G., Foster, C. A., & Sharp, B. M. (1993) · Endocrinology · doi:10.1210/endo.133.6.8243321 · Cited by 30 · cited 2×
“…in animal studies (see " Acute nicotine treatment regimens " and " Repeated injection " ), because it not only alters general metabolism but also effects several nicotine-responsive neurotransmitter systems (Balfour 1991; Benwell and Balfour 1982; Matta et al. 1993, 1998; Takahashi et al. 2000).”
BackgroundSelf-citationEbihara, M., Ohba, H., Ohno, S.-I., & Yoshikawa, T. (2002) · Gene · doi:10.1016/s0378-1119(02)00925-3 · Cited by 30
Variables affecting nicotine metabolism
Seaton, M. J., & Vesell, E. S. (1993) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(93)90032-9 · Cited by 30 · cited 1×
“The metabolism in primates is comparable to that in humans (Seaton et al. 1991), but other animals metabolize nicotine more rapidly (Gorrod and Jenner 1975; Scheline 1978; Seaton and Vesell 1993).”
BackgroundShort-term distribution of nicotine in the rat lung
Brewer, B. G., Roberts, A. M., & Rowell, P. P. (2004) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2004.02.011 · Cited by 30 · cited 1×
“Such similarity could be explained by a recent animal (rat) study demonstrating that the lung serves as an initial depot for nicotine and retards its entry into arterial circulation (Brewer et al. 2004).”
BackgroundDeterminants of the Voluntary Consumption of Nicotine by Rats
Maehler, R., Dadmarz, M., & Vogel, W. H. (2000) · Neuropsychobiology · doi:10.1159/000026660 · Cited by 29
Gilbert, D. G., Jensen, R. A., & Meliska, C. J. (1988) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(88)90403-0 · Cited by 28 · cited 1×
“Several methods of controlling puff volume and inhalation volume have been devised, which can effectively regulate the dose of nicotine inhaled (Gilbert et al. 1989; Levin et al. 1989; Pomerleau et al. 1989; Rose et al. 1985; Tashkin et al. 1991).”
MethodAcetylcholine receptor molecules of the nematode Caenorhabditis elegans
Fleming, J. T., Tornøe, C., Riina, H. A., Coadwell, J., Lewis, J. A., & Sattelle, D. B. (1993) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-7265-2_4 · Cited by 28
Nicotine metabolism in stumptailed macaques, Macaca arctoides.
Seaton, M. J., Kyerematen, G. A., Morgan, M. L., Jeszenka, E. V., & Vesell, E. S. (1991) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)08975-5 · Cited by 28 · cited 1×
“The metabolism in primates is comparable to that in humans (Seaton et al. 1991), but other animals metabolize nicotine more rapidly (Gorrod and Jenner 1975; Scheline 1978; Seaton and Vesell 1993).”
BackgroundBehavioural pharmacology of nicotine in animals
Stolerman, I. P. (1990) · Oxford University Press eBooks · doi:10.1093/oso/9780192616142.003.0008 · Cited by 28
Self-citation(1993) · Techniques in the behavioral and neural sciences · doi:10.1016/b978-0-444-81444-9.50014-6 · Cited by 27
Analyzing the acquisition of drug self-administration using growth curve models☆
Lanza, S. T., Donny, E. C., Collins, L. M., & Balster, R. L. (2004) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2004.02.006 · Cited by 26 · cited 1×
“This PR behavior demonstrates a more persistent self-administration despite increasing behavioral costs and reflects motivation to work for the drug (Corrigall et al. 2001; Donny et al. 1999, 2000; Lanza et al. 2004; Paterson et al. 2004).”
BackgroundSelf-citationDing, Y., Volkow, N. D., Logan, J., Garza, V., Pappas, N. R., King, P. T., & Fowler, J. S. (2000) · Synapse · doi:10.1002/(sici)1098-2396(20000301)35:3<234::aid-syn9>3.0.co;2-7 · Cited by 26 · cited 2×
“Baboons (Papio) and rhesus monkeys (M. mulatta) have been given nicotine doses ranging from 5 to 40 μg kg −1 (Ding et al. 2000; Fowler et al. 1998; Valette et al. 2003) or 0.01–0.065 mg kg −1 (3–20 μg kg −1 ) (Marenco et al. 2004).”
MethodInfluentialNicotine activates NPY and catecholaminergic neurons in brainstem regions involved in ACTH secretion
Matta, S. G., Valentine, J. D., & Sharp, B. M. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00266-7 · Cited by 26
Self-citationHildebrand, B. E., & Svensson, T. (2000) · Journal of neural transmission · doi:10.1007/s007020070038 · Cited by 24 · cited 1×
“1992), as well as changes in neurotransmitter release in discrete brain sites (Carboni et al. 2000; Hildebrand et al. 1998, 1999; Hildebrand and Svensson 2000; Panagis et al. 2000) that are considered to underlie drug dependence processes.”
BackgroundHorowitz, J. M., Kristal, M. B., & Torres, G. (1997) · Synapse · doi:10.1002/(sici)1098-2396(199705)26:1<62::aid-syn7>3.0.co;2-c · Cited by 24
Damaj, M. I. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.092460 · Cited by 24
Self-citationOral nicotine solution for smoking cessation: a pilot tolerability study
Westman, E. C., Tomlin, K. F., Perkins, C. E., & Rose, J. E. (2001) · Nicotine & Tobacco Research · doi:10.1080/14622200126973 · Cited by 23 · cited 1×
“In addition, it recently has been shown that orally administered nicotine can be well tolerated and yields plasma levels comparable to other forms of NRT in the range of 6–22 ng ml −1 (0.04–0.14 μM) (Westman et al. 2001).”
BackgroundInfluentialSelf-citationDifferences Between Alcohol-Preferring and Alcohol-Nonpreferring Rats in Ethanol Generalization
McMillan, D. E., Li, M., & Shide, D. J. (1999) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(99)00053-2 · Cited by 22
Colpaert, F. C. (1991) · Behavioural Pharmacology · doi:10.1097/00008877-199109000-00004 · Cited by 22
Tolerance to nicotine in mice lacking α7 nicotinic receptors
Naylor, C. G., Quarta, D., Fernandes, C., & Stolerman, I. P. (2005) · Psychopharmacology · doi:10.1007/s00213-005-2187-5 · Cited by 21
Self-citationPalmatier, M. I., Fung, E. Y. K., & Bevins, R. A. (2003) · Behavioural Pharmacology · doi:10.1097/00008877-200305000-00002 · Cited by 21 · cited 1×
“to drug-naive adult male rats who have not been habituated to the testing apparatus and, thus, would be expected to show high initial levels of exploratory behavior without the drug (e.g., Clark and Kumar 1983; Palmatier et al. 2003; Stolerman 1990).”
BackgroundControlling puff volume without disrupting smoking topography
Levin, E. D., Rose, J. E., & Behm, F. M. (1989) · Behavior Research Methods, Instruments, & Computers · doi:10.3758/bf03202801 · Cited by 20 · cited 1×
“Several methods of controlling puff volume and inhalation volume have been devised, which can effectively regulate the dose of nicotine inhaled (Gilbert et al. 1989; Levin et al. 1989; Pomerleau et al. 1989; Rose et al. 1985; Tashkin et al. 1991).”
MethodSelf-citationWatanabe, H., Zoli, M., & Changeux, J. (1998) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1998.00235.x · Cited by 20
Adrenalectomy reverses chronic injection-induced tolerance to nicotine
Grun, E. U., Pauly, J. R., & Collins, A. C. (1992) · Psychopharmacology · doi:10.1007/bf02245877 · Cited by 19 · cited 1×
“The role of adrenal hormones in this manifestation of tolerance observed after repeated injections is supported by the elimination of tolerance after adrenalectomy (Grun et al. 1992) and the induction of tolerance after implantation of corticosterone pellets (Pauly et al.”
BackgroundSelf-citationCarrillo, R. J., & Gibson, G. C. (2002) · Genetics Research · doi:10.1017/s0016672302005888 · Cited by 18
Chronic effects of nicotine on mesolimbic dopaminergic system in rats
Fung Yiu, K., & Lau, Y. (1992) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(92)90059-o · Cited by 18
Oral contraceptives induce CYP2A6 activity and accelerate nicotine metabolism
Benowitz, N. L. (2004) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2003.11.135 · Cited by 17 · cited 1×
“Women metabolize both nicotine and cotinine more rapidly than men do, with 13 and 26% higher clearance rates, respectively (Benowitz et al. 2004).”
BackgroundSelf-citationFu, Y., Matta, S. G., Valentine, J. D., & Sharp, B. M. (1998) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00018-4 · Cited by 17
Self-citationTemporal factors in drug discrimination: Experiments with nicotine
Stolerman, I. P., & Garcha, H. S. (1989) · Journal of Psychopharmacology · doi:10.1177/026988118900300207 · Cited by 17 · cited 1×
“The time between nicotine administration and behavioral testing also has a profound effect on quantitative aspects of nicotine discrimination (Stolerman and Garcha 1989).”
BackgroundSelf-citationNeuron-specific gene manipulations to transparent zebrafish embryos
Yoshida, T., & Mishina, M. (2003) · Methods in Cell Science · doi:10.1023/b:mics.0000006850.81427.ed · Cited by 17 · cited 1×
“It also is relatively easy to construct strains of transgenic zebrafish expressing new genes or markers, such as green fluorescent protein (GFP), under control of specific promoters (Higashijima et al. 2000; Yoshida and Mishina 2003).”
BackgroundGenetic analysis of nicotinic signaling in worms and flies
Schafer, W. R. (2002) · Journal of Neurobiology · doi:10.1002/neu.10154 · Cited by 15 · cited 1×
“elegans is an outstanding model system in which to address nicotinic signaling at physiological, genetic, and behavioral levels (Schafer 2002).”
BackgroundSelf-citationHieber, V. C., Bouchey, J., Agranoff, B. W., & Goldman, D. J. (1990) · Nucleic Acids Research · doi:10.1093/nar/18.17.5307 · Cited by 14
Decapitated Drosophila: A Novel System for the Study of Biogenic Amines
Hirsh, J. (1997) · Advances in pharmacology · doi:10.1016/s1054-3589(08)60903-5 · Cited by 13 · cited 1×
“The application of drugs to the thorax opening of a decapitated fly (Hirsh 1998; Yellman et al. 1998) has been used to score behaviors, such as grooming, spinning, and extended hyperactivity, on a qualitative scale (Ashton et al.”
MethodHowell, L. L. (1995) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)09565-5 · Cited by 13
Hieber, V. C., Bouchey, J., Agranoff, B. W., & Goldman, D. J. (1990) · Nucleic Acids Research · doi:10.1093/nar/18.17.5293 · Cited by 11
Smoking less as a treatment goal for those who cannot stop smoking
Benowitz, N. L. (2004) · The American Journal of Medicine · doi:10.1016/j.amjmed.2003.11.009 · Cited by 9 · cited 2×
“…studies of high-dose NRT, using multiple skin patches or combinations of two or more forms of NRT, have found no evidence of serious toxic effects (Benowitz 2004; Benowitz et al. 1998; Schuurmans et al. 2004; Working Group for the Study of Transdermal Nicotine in Patients with Coronary Artery…”
BackgroundSelf-citationTakahashi, H., Takada, Y., Nagai, N., Urano, T., & Takada, A. (2000) · Brain Research Bulletin · doi:10.1016/s0361-9230(00)00267-7 · Cited by 8 · cited 1×
“…in animal studies (see " Acute nicotine treatment regimens " and " Repeated injection " ), because it not only alters general metabolism but also effects several nicotine-responsive neurotransmitter systems (Balfour 1991; Benwell and Balfour 1982; Matta et al. 1993, 1998; Takahashi et al. 2000).”
BackgroundDeterminants of nicotine self-administration
Shoaib, M. C. (1996) · Drug Development Research · doi:10.1002/(sici)1098-2299(199607/08)38:3/4<212::aid-ddr10>3.0.co;2-0 · Cited by 8
A noninvasive method for delivering controlled doses of nicotine via cigarette smoke
Pomerleau, O. F., Rose, J. E., Pomerleau, C. S., & Majchrzak, M. J. (1989) · Behavior Research Methods, Instruments, & Computers · doi:10.3758/bf03210582 · Cited by 6 · cited 1×
“Several methods of controlling puff volume and inhalation volume have been devised, which can effectively regulate the dose of nicotine inhaled (Gilbert et al. 1989; Levin et al. 1989; Pomerleau et al. 1989; Rose et al. 1985; Tashkin et al. 1991).”
MethodSelf-citationFung, Y. K., & Lau, Y. (1991) · General Pharmacology The Vascular System · doi:10.1016/0306-3623(91)90320-6 · Cited by 6
Behavioral and Biochemical Analysis of the Dependence Properties of Nicotine
Yanagita, T., Ando, K., Wakasa, Y., & Shimada, A. (1995) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-7445-8_29 · Cited by 5
Cardiovascular Toxicity of Nicotine: Pharmacokinetic and Pharmacodynamic Considerations
Benowitz, N. (1998) · doi:10.1093/oso/9780195114966.003.0002 · Cited by 4
Self-citationInsecticide resistance in Drosophila
Boundy, S. (2003) · OpenGrey (Institut de l'Information Scientifique et Technique) · Cited by 2
Terry (1999) · doi:10.1002/(sici)1098-2299(199907)47:3
Self-citationNicotine Replacement Therapy for Patients With Coronary Artery Disease
(1994) · Archives of Internal Medicine · doi:10.1001/archinte.1994.00420090063007
Research works printed but not linked: 3
- Dworkin SI, Vrana SL, Broadbent J, Robinson J (1993) Comparing the reinforcing effects of nicotine, caffeine, methylphenidate and cocaine. Med Chem Res 2:593–602
- Järbe TUC (1989) Discrimination learning with drug stimuli. In: Boulton AA, Baker GB, Greenshaw AJ (eds) Neuromethods, vol 13. Humana, Clifton, New Jersey, pp 513–563
- Levin ED, Christopher NC, Briggs SJ (1994) Comparison of chronic nicotine and mecamylamine effects on working memory performance in the radial-arm maze and T-maze alternation. Soc Neurosci Abs 20:151
Cited by
Habenular α5 nicotinic receptor subunit signalling controls nicotine intake
Fowler, C. D., Lu, Q., Johnson, P. M., Marks, M. J., & Kenny, P. J. (2011) · Nature · doi:10.1038/nature09797 · Cited by 663
Self-citationPICCIOTTO, M., ADDY, N., MINEUR, Y., & BRUNZELL, D. (2008) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2007.12.005 · Cited by 460
Self-citationNicotine Decreases Food Intake Through Activation of POMC Neurons
Mineur, Y. S., Abizaid, A., Rao, Y., Salas, R., DiLeone, R. J., Gündisch, D., Diano, S., De Biasi, M., Horvath, T. L., Gao, X.-B., et al. (2011) · Science · doi:10.1126/science.1201889 · Cited by 439
Self-citationPhasic Dopamine Release Evoked by Abused Substances Requires Cannabinoid Receptor Activation
Cheer, J. F., Wassum, K. M., Sombers, L. A., Heien, M. L. A. V., Ariansen, J. L., Aragona, B. J., Phillips, P. E. M., & Wightman, R. M. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4152-06.2007 · Cited by 374
“3 mg/kg) were administered intravenously at doses demonstrated previously to have robust effects either on dopamine extracellular concentrations or behavior (Di Chiara and Imperato, 1988; Budygin et al., 2001; Robinson et al., 2002a; Heien et al., 2005; Matta et al., 2006).”
MethodInfluentialNicotine and the renin-angiotensin system
Oakes, J. M., Fuchs, R. M., Gardner, J. D., Lazartigues, E., & Yue, X. (2018) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00099.2018 · Cited by 312
Metadata
- Authors
- Matta, S. G., Balfour, D. J., Benowitz, N. L., Boyd, R. T., Buccafusco, J. J., Caggiula, A. R., Craig, C. R., Collins, A. C., Damaj, M. I., Donny, E. C., Gardiner, P. S., Grady, S. R., Heberlein, U., Leonard, S. S., Levin, E. D., Lukas, R. J., Markou, A., Marks, M. J., McCallum, S. E., Parameswaran, N., Perkins, K. A., Picciotto, M. R., Quik, M., Rose, J. E., Rothenfluh, A., Schafer, W. R., Stolerman, I. P., Tyndale, R. F., Wehner, J. M., & Zirger, J. M.
- Affiliations
- University of Tennessee Health Science Center (US)
- University of Dundee (GB)
- University of California, San Francisco (US)
- The Ohio State University (US)
- Augusta University (US)
- University of Pittsburgh (US)
- University of California San Diego (US)
- University of Colorado Boulder (US)
- Virginia Commonwealth University (US)
- University of California System (US)
- University of Colorado Health (US)
- Duke Medical Center (US)
- Barrow Neurological Institute (US)
- Parkinson's Institute and Clinical Center (US)
- Yale University (US)
- King's College London (GB)
- Centre for Addiction and Mental Health (CA)
- Corresponding author
- Matta, Shannon G.
- ORCID
- Venue
- Psychopharmacology
- Published
- 2006-08-09
- Volume
- 190
- Issue
- 3
- Pages
- 269-319
- ISSN
- 0033-3158 (ISSN-L)
- 1432-2072
- OpenAlex
- W2151079096
- Semantic Scholar
- a869fec78dfce26c04bde5b3ac55aa2e33388cc6
- Cited by
- 824
- References
- 446
- Citations by year
- 2026: 23 · 2025: 27 · 2024: 35 · 2023: 35 · 2022: 34 · 2021: 44 · 2020: 48 · 2019: 48 · 2018: 42 · 2017: 54 · 2016: 51 · 2015: 66 · 2014: 56 · 2013: 63 · 2012: 53
- FWCI
- 3.33
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Lirias (submittedVersion)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
- Health Sciences › Veterinary › Small Animals › Animal testing and alternatives
- Keywords
- nicotine, dose selection, dosing regimen, route of administration, species differences, nicotine metabolism, dose-response relationship, nicotine dependence, nicotine tolerance, nicotine withdrawal, nicotine replacement therapy, cigarette smoking, animal models, Drosophila, Caenorhabditis elegans, zebrafish, rats, mice, non-human primates
- MeSH terms
- Animals, Dose-Response Relationship, Drug, Ganglionic Stimulants, Humans, Models, Biological, Nicotine, Species Specificity, Guidelines as Topic, Behavioral Research
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.